Back to search

United Kingdom· GB-APID-40864711000001100

Ceftazidime 1g powder for solution for injection vials

A ceftazidime product containing ceftazidime, registered in United Kingdom by Tillomed Laboratories Ltd. The same ATC class is registered in 18 of our 19 countries.

ATC J01DD02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedCeftazidime 1g powder for solution fo…ATCJ01DD02REGISTER NO.GB-APID-4086471100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Ceftazidime is registered in 18 of 19 countries.

Countries holding a registration under ATC J01DD02 (ceftazidime), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Ceftazidime · ATC J01DD02

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ceftazidime costs, country by country.

Normalised to the WHO defined daily dose (4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ceftazidime · price per daily dose (4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$129.98
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Ceftazidime
Manufacturer
Tillomed Laboratories Ltd
Country
United Kingdom (GB)
ATC code
J01DD02
ATC class
Ceftazidime
Defined daily dose
4 g, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    8434805000095

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

155 interactions on record for ceftazidime.

Graded by severity as the source publishes them — 34 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ceftazidime · interactions on record

155 records

  • 34 moderate
  • 121 info

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • NeomycinA07AA01moderate
  • StreptomycinA07AA04moderate
  • Amphotericin BA07AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ceftazidime in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ceftazidime products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ceftazidim Aptapharma, Ceftazidim Hameln
  • Belgium · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • Bulgaria · Алфагем, Зидимцеф
  • Cyprus · Alfagem, Cezid
  • Czechia · Altecim, Ceftazidim Aptapharma
  • Germany · Ceftazidim Dr. Eberth, Ceftazidim Hameln
  • Denmark · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • Estonia · Altecim, Ceftazidime Fresenius Kabi
  • Spain · Alfagem, Ceftazidima Kabi
  • Finland · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • France · Ceftazidime Arrow, Ceftazidime Enfants Et Nourrissons Panpharma
  • Greece · Alfagem, Ceftaridem
  • Croatia · Altecim, Cefaz
  • Hungary · Ceftazidim Aptapharma, Ceftazidim Kabi
  • Ireland · Ceftazidime Hameln, Ceftazidime Hikma Farmacêutica
  • Iceland · Ceftazidim Fresenius Kabi, Ceftazidima Normon
  • Italy · Ceftazidima Almus, Ceftazidima Astro-Pharma
  • Lithuania · Biotum, Ceftazidime Kabi
  • Luxembourg · Ceftazidim Fresenius Kabi, Glazidim
  • Latvia · Ceftazidime Fresenius Kabi, Ceftazidime Mip
  • Malta · Alfagem, Ceftazidima Fresenius
  • Netherlands · Ceftazidim (Im/Iv) Mip, Ceftazidim (Iv) Mip
  • Norway · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
  • Poland · Biotum, Ceftazidim Aptapharma
  • Portugal · Alfagem, Ceftazidima Accord
  • Romania · Alfagem, Ceftamil
  • Sweden · Ceftazidim Hameln, Fortum
  • Slovenia · Ceftazidim Aptapharma, Ceftazidim Kabi
  • Slovakia · Ceftazidim Ash, Ceftazidim Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c64a95ff-9122-4e19-a07c-54b3880b64bd
GET /v1/drugs/c64a95ff-9122-4e19-a07c-54b3880b64bd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "40864711000001100",
  "desc": "Ceftazidime 1g powder for solution for injection vials (Tillomed Laboratories Ltd)",
  "form": "Powder for solution for injection",
  "vpid": "41944811000001100",
  "source": "dmd",
  "vtm_id": "775115003",
  "strength": "1 gram",
  "substance": "Ceftazidime",
  "ingredient": "Ceftazidime pentahydrate",
  "supplier_code": "2089201000001102"
}

See everything about ceftazidime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.